A proud moment for the CergenX team yesterday in Boston, as we met with Minister @peterburkefg to discuss our recent FDA Breakthrough Device Designation for Wave—our AI-powered neonatal neurotech device. Our thanks to @Entirl for their continued support!
Delighted to be here in San Diego—let’s connect and explore how our AI-powered tech is advancing newborn brain assessment. Reach out at [email protected] to schedule a meeting or drop by Booth 5.
@NewbornBrains#INBBC#INBBC25#INBBC2025
Our seizure detection paper is finally out! First of many for @CergenX with our friends in INFANT.
Published in npj Digital Medicine.
This represents a significant milestone for the field with the first ever demonstration of human expert level performance on held out datasets.
👏 Huge congratulations to INFANT, @UCC spinout, @CergenX who secured @FDA support for their neonatal brain injury device.
More:📰🔽 https://t.co/lxH3VgXwKA
Congratulations to UCC & @infantcentre spin-out company @CergenX, who have secured U.S. Food and Drug Administration (FDA) support for their neonatal #Wave brain injury device. Learn more: https://t.co/HPSOXxAUaK
CergenX is at #IPA2024 in Cork today & tomorrow.
Stop by our stand to:
-discover how our tech can advance newborn brain health outcomes
-get a live demo of the CergenX Wave device
-find out more about our clinical trials & plans for 2025 and beyond!
#IrishPaediatricAssociation
Congratulations to @UCC & @infantcentre spin-out company @CergenX on winning the @IrishTimes Life Sciences & Healthcare Innovation Award sponsored by @Researchirel. Learn more about how UCC Innovation has supported CergenX here: https://t.co/8dxv1YcoRe
Thank you @CergenX for sharing about our global advocacy efforts for #HIE, and for all you are doing to change the trajectory of HIE babies and their families.
https://t.co/Ml3ZgAPOj2
#HopeforHIE#NeoTwitter#NeuroTwitter
Huge congratulations to INFANT, @UCC spinout @CergenX on winning the Irish Times Life Sciences & Healthcare Innovation Award sponsored by @Researchirel. This award recognises their innovation in neonatal brain monitoring. 👏
@uccinnovation | @UCCResearch | @IrishTimesBiz |
Congrats to INFANT, UCC spin-out company @CergenX who are a finalist in @IrishTimes Innovation Awards.
Best of luck in the final!! 👏
Learn more about CergenX here: https://t.co/ZuOa2w8rKK
@uccinnovation
Exciting news! Our 1st product, the CergenX Wave device, is now being tested on newborns in a hospital environment as part of a Feasibility Study.
Our thanks to @infantcentre@UCC & @CUH_Cork + all parents who consented to their newborns participating.
#BrainInjury#AiForGood
We are proud to announce that we have achieved ISO 13485:2016 certification for our QMS.
This certification sets the benchmark for quality management in the medical device industry, reinforcing our commitment to delivering safe, high-quality products.
#MedTechInnovation
Our Head of AI Research, Dr John O'Toole has just returned from presenting at the PARENT/AI-4-NICUTraining School "AI in the Clinic" in Turin
A great mix of in-depth presentations, tutorials & discussions
Our thanks to @ITN_PARENT and @Ai4Nicu#AiForGood#MedTechInnovation#EEG
Last week Prof Lina Chalak (who serves on our Scientific Advisory Board) gave a fascinating lecture on new horizons for mild encephalopathy in newborns @CUH_Cork —part of @UCC Futures:Children Seminar Series. Often not qualifying for cooling, more research is needed in this area.
The voices of patients are often inexplicably absent in #MedTech & #HealthcareInnovation
In this compelling article, Mandy Daly, founder of @IrishNeonatal shares her insights from almost 20 years of advocacy for #preterm babies & their families:
➡️ https://t.co/ddosvAM5Nn